US EditionK2 Medical Research Brings New Clinical Trials Program to Rhode Island, Honors Clinical Research Day 2025
- K2 Medical Research announced a new clinical trials program on May 19, 2025, in East Providence, Rhode Island.
- This program was established to provide cutting-edge clinical trial options in Southern New England and focuses on addressing difficult health issues such as Alzheimer's disease.
- K2's East Providence location is recruiting participants for two Alzheimer's studies that focus on various stages of the disease, along with a separate trial testing a new treatment aimed at alcohol use disorder.
- The Alzheimer's Association reports that more than 7 million people in the U.S. Are living with Alzheimer's disease, with close to 12 million family members and friends providing unpaid care, resulting in an estimated economic burden of $384 billion.
- K2 will support local awareness through educational seminars, community talks, and mascot appearances, aiming to enhance health outcomes locally and globally.
Insights by Ground AI
Does this summary seem wrong?
36 Articles
36 Articles
All
Left
4
Center
8
Right
3
Bennington Banner+33 Reposted by 33 other sources
K2 Medical Research Brings New Clinical Trials Program to Rhode Island, Honors Clinical Research Day 2025
EAST PROVIDENCE, R.I., May 19, 2025 /PRNewswire/ -- K2 Medical Research is proud to introduce its newest clinical trials program in East Providence, bringing innovative research opportunities to Southern New England. As a privately owned clinical research facility, K2 is…
Coverage Details
Total News Sources36
Leaning Left4Leaning Right3Center8Last UpdatedBias Distribution53% Center
Bias Distribution
- 53% of the sources are Center
53% Center
L 27%
C 53%
R 20%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
